Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
The company will submit its comprehensive response on these observations to the USFDA
The company will submit its comprehensive response on these observations to the US FDA
The company has extended its full co-operation and support to the officials of the Income Tax Department
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
Subscribe To Our Newsletter & Stay Updated